Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study

10 Oct 2024

Abstract excerpt

We aimed to explore novel biomarker candidates and biomarker signatures of late-onset preeclampsia (LOPE) by profiling samples collected in a longitudinal discovery cohort with a high-throughput proteomics platform. Using the Somalogic 5000-plex platform, we analyzed proteins in plasma samples collected at three visits (gestational weeks (GW) 12-19, 20-26 and 28-34 in 35 women with LOPE (birth ≥ 34 GW) and 70...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to MicroRNA in disease regulation
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39390022
DOI: 10.1038/s41598-024-73796-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics studyPMID 39390022Read ↗

Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsiaSemantic proximity Read ↗

Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsiaSemantic proximity Read ↗

First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot StudySemantic proximity Read ↗

Molecular subclasses of preeclampsia characterized by a longitudinal maternal proteomics study: distinct biomarkers, disease pathways and options for preventionSemantic proximity Read ↗

Determination of biomarker candidates for the placenta accreta spectrum by plasma proteomic analysisSemantic proximity Read ↗

Integration of Single-Cell Sequencing and Transcriptomic Analysis to Identify Novel Diagnostic Biomarkers for Preeclampsia and Explore Changes in Immune Cell InteractionsSemantic proximity Read ↗

Identification of key extracellular proteins as biomarkers for prediction and assessment of preeclampsiaSemantic proximity Read ↗

Proteomic analysis of human serum for Finding pathogenic factors and potential biomarkers in preeclampsiaSemantic proximity Read ↗

Late first trimester circulating microparticle proteins predict the risk of preeclampsia < 35 weeks and suggest phenotypic differences among affected cases.Semantic proximity Read ↗

Rethinking Risk Prediction in Preeclampsia: From Biomarkers to Mechanistic Phenotypes and Longitudinal Models.Semantic proximity Read ↗

Clinical tools and biomarkers to predict preeclampsiaSemantic proximity Read ↗

Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.